Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Enanta Pharmaceuticals (ENTA) Change in Account Payables (2016 - 2025)

Enanta Pharmaceuticals filings provide 14 years of Change in Account Payables readings, the most recent being -$63000.0 for Q4 2025.

  • On a quarterly basis, Change in Account Payables rose 62.5% to -$63000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$1.2 million, a 79.05% increase, with the full-year FY2025 number at -$1.3 million, down 216.67% from a year prior.
  • Change in Account Payables hit -$63000.0 in Q4 2025 for Enanta Pharmaceuticals, up from -$723000.0 in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $6.6 million in Q1 2023 to a low of -$5.1 million in Q2 2022.
  • Median Change in Account Payables over the past 5 years was -$623000.0 (2021), compared with a mean of -$218700.0.
  • Biggest five-year swings in Change in Account Payables: skyrocketed 1796.21% in 2021 and later crashed 2923.33% in 2022.
  • Enanta Pharmaceuticals' Change in Account Payables stood at -$1.7 million in 2021, then surged by 58.75% to -$686000.0 in 2022, then soared by 854.23% to $5.2 million in 2023, then plummeted by 103.25% to -$168000.0 in 2024, then soared by 62.5% to -$63000.0 in 2025.
  • The last three reported values for Change in Account Payables were -$63000.0 (Q4 2025), -$723000.0 (Q3 2025), and -$1.3 million (Q2 2025) per Business Quant data.